A Phase I/II Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC Patients who are BCG Na�ve or Received Incomplete BCG Treatment LEGEND STUDY

Brief Summary

Type:
Bladder

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT04752722

Study #:
STUDY00148967

Start Date:
May 29, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04752722

View Complete Trial Details & Eligibility at ClinicalTrials.gov